SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 37,620 | $775,000 | 0.00% |
| Creative Planning | 100 | $2,058 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 44,077 | $907,105 | 0.00% |
| North Star Investment Management Corp. | 194 | $3,993 | 0.00% |
| Leucadia National | 2,000 | $41,160 | 0.00% |
| TD Waterhouse Canada Inc. | 100 | $1,977 | 0.00% |
| Invesco Ltd. | 66,245 | $1,363,322 | 0.00% |
| WOLVERINE TRADING, LLC | 13,700 | $281,946 | 0.00% |
| Farther Finance Advisors, LLC | 7 | $144 | 0.00% |
| ORG Partners LLC | 5 | $102 | 0.00% |
External links
This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.